Literature DB >> 31556915

US Food and Drug Administration Regulatory Programs for Innovative Technologies.

Frank Brodie1, Tieuvi Nguyen2, Malvina Eydelman2.   

Abstract

Entities:  

Year:  2019        PMID： 31556915      PMCID： PMC8132507          DOI： 10.1001/jamaophthalmol.2019.3708

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  3 in total

1.  The US Food and Drug Administration's New Regulatory Toolkit to Bring Medical Device Innovation Back to the United States.

Authors:  Malvina B Eydelman; Tieuvi Nguyen; J Angelo Green
Journal:  JAMA Ophthalmol       Date:  2016-04       Impact factor: 7.389

2.  Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study.

Authors:  Nisha R Acharya; Vivien M Tham; Elizabeth Esterberg; Durga S Borkar; John V Parker; Aleli C Vinoya; Aileen Uchida
Journal:  JAMA Ophthalmol       Date:  2013-11       Impact factor: 7.389

Review 3.  Clinical characteristics and current therapies for inherited retinal degenerations.

Authors:  José-Alain Sahel; Katia Marazova; Isabelle Audo
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-16       Impact factor: 6.915
  3 in total
  1 in total

Review 1.  Ethics of Artificial Intelligence in Medicine and Ophthalmology.

Authors:  Yasser Ibraheem Abdullah; Joel S Schuman; Ridwan Shabsigh; Arthur Caplan; Lama A Al-Aswad
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2021 May-Jun 01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.